biological · Product Intelligence

Botulinum Toxin Type A
Pipeline Intelligence

Botulinum Toxin Type A: 5 indexed trials, 3 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
5Indexed trials
▦
3Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT00477802University of Cincinnati · parkinsonsPHASE4
NCT01313299Ipsen · other_neurologyPHASE3
NCT01753310Ipsen · movement_disordersPHASE3
NCT03462290Norwegian University of Science and Technology · pain_neuropathyPHASE2
NCT06047444Ipsen · migraine_headachePHASE3

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.